After IAP exit, Hyderabad paediatrician Sivaranjani Santosh alleges pharma influence, seeks probe into ORSL promotion
Dr. Sivaranjani Santosh has publicly criticized the Indian Academy of Paediatrics (IAP) leadership following her resignation, alleging undue influence from pharmaceutical companies. She is now calling for an investigation into the promotion of ORSL products.
Why it matters
The case raises significant ethical questions regarding the relationship between medical professional bodies and the pharmaceutical industry.
Hyderabad-based paediatrician Dr Sivaranjani Santosh has said that her resignation from the Indian Academy of Paediatrics (IAP), which she submitted nearly two months ago, has now been formally accepted by the organisation. In a post on social media platform X, Dr Santosh said that the acceptance of her resignation had freed her from any obligation to remain restrained in criticising the academy’s leadership. “So far, I had to show some restraint before calling the leadership out for their pathetic slavery to pharma. Now, I am under no obligation to show that restraint,” she wrote.
The article focuses on a whistleblower's perspective, highlighting allegations of corporate influence in medical institutions.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in